On March 24, 2010
Medical Journals: Still Too Lazy to ID Pharma-Funded Research
GlaxoSmithKline (GSK) is taking heat today over an editorial in the Journal of the American Medical Association describing a “disturbing example of inappropriate conduct” over studies for the company’s diabetes drug Avandia. Some of the heat is deserved but the
…
0 Comments